Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Pharmalogic ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.9% 0.9%   Bankruptcy risk   0.0% 0.0% 0.0% 6.1% 3.0% 2.5% 11.5% 11.5%   Credit score (0-100)   0 0 0 37 57 61 21 21   Credit rating   N/A N/A N/A BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 0.0 3,241 7,396 14,961 0.0 0.0   EBITDA   0.0 0.0 0.0 678 823 1,821 0.0 0.0   EBIT   0.0 0.0 0.0 678 743 1,730 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 0.0 677.2 705.0 1,696.1 0.0 0.0   Net earnings   0.0 0.0 0.0 523.7 578.4 1,293.9 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 0.0 677 705 1,696 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 239 164 0.0 0.0   Shareholders equity total   0.0 0.0 0.0 564 1,142 1,936 896 896   Interest-bearing liabilities   0.0 0.0 0.0 9.8 396 82.4 0.0 0.0   Balance sheet total (assets)   0.0 0.0 0.0 1,348 3,629 4,715 896 896   Net Debt   0.0 0.0 0.0 -104 371 82.4 -896 -896     See the entire balance sheet 1000.0 Volume  2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 0.0 3,241 7,396 14,961 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 0.0% 128.2% 102.3% -100.0% 0.0%   Employees   0 0 0 2 7 11 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 250.0% 57.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 0 1,348 3,629 4,715 896 896   Balance sheet change%   0.0% 0.0% 0.0% 0.0% 169.3% 29.9% -81.0% 0.0%   Added value   0.0 0.0 0.0 678.2 743.1 1,820.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 -0 160 -166 -164 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 0.0 0.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 0.0% 20.9% 10.0% 11.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 0.0% 0.0% 50.3% 29.9% 41.5% 0.0% 0.0%   ROI %   0.0% 0.0% 0.0% 118.3% 70.4% 97.3% 0.0% 0.0%   ROE %   0.0% 0.0% 0.0% 92.9% 67.8% 84.1% 0.0% 0.0%   1000.0 Solidity  2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% 0.0% 41.8% 31.5% 41.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% -15.3% 45.1% 4.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 1.7% 34.6% 4.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 19.5% 18.8% 14.0% 0.0% 0.0%   1000.0 Liquidity  2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.0 1.7 1.1 1.3 0.0 0.0   Current Ratio   0.0 0.0 0.0 1.7 1.1 1.3 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 113.9 24.6 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 0.0 563.7 127.7 751.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 N/A 2019 N/A 2020 N/A 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 339 106 166 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 339 118 166 0 0   EBIT / employee   0 0 0 339 106 157 0 0   Net earnings / employee   0 0 0 262 83 118 0 0